Boehringer Ingelheim (France)
In research, Boehringer Ingelheim (France) stands highest in Medicine (#4,638 of 17,978 worldwide) and Health Sciences (#6,316 of 20,462 worldwide), over all time.
- World rank, 2022–2025
- #18,415 of 28,054 · #11,755 all time
- Rank in France
- #848 of 1,422
- Research works
- 383 ▲ 20% vs 2013–17
- Citations
- 14k 36.3 per fractional work
- Top-10% rate
- 14.8% record average 16.5%
- Open access
- 41% world 28%
What is Boehringer Ingelheim (France) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #4,638 of 17,978 | 21.2% | 198 | |
| Health SciencesDomain | #6,316 of 20,462 | 20.4% | 213 |
Each strip is that field’s whole ranked pool, with the notch where Boehringer Ingelheim (France) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 20.4×. Every wedge is a field page.
- Veterinary 20.4×
- Pharmacology, Toxicology and Pharmaceutics 10.3×
- Immunology and Microbiology 9.8×
- Medicine 2.5×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Agricultural and Biological Sciences 1.6×
- Chemistry 1.5×
- Mathematics 0.9×
- Neuroscience 0.7×
- Chemical Engineering 0.6×
- Nursing 0.6×
- Economics, Econometrics and Finance 0.5×
- Health Professions 0.5×
- Psychology 0.4×
- Environmental Science 0.3×
- Materials Science 0.3×
- Computer Science 0.2×
- Engineering 0.2×
- Arts and Humanities 0.2×
- Energy 0.2×
- Decision Sciences 0.2×
- Physics and Astronomy 0.1×
- Social Sciences 0.0×
Who are the top researchers at Boehringer Ingelheim (France)?
Ranked on the composite score, M Girard lead among researchers whose main affiliation is Boehringer Ingelheim (France).
- 1 M Girard France · #1,116,517 worldwide 5 citations · 30 works
Which keywords describe research at Boehringer Ingelheim (France)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Public Health, Diagnosis, Vaccine, Fibrosis, TGF-ß and Interstitial Lung Disease.
- Norovirus
- Coronavirus
- Treatment Guidelines
- Metagenomics
- Pathogen Transmission
- Genomic Sequencing
- Ivermectin
- Immunosuppressive Therapy
- Infection
- Immunotherapy
- Biomarkers
- Autoantibodies
- Heart Failure
- Myofibroblast
- Immune Response
- Interstitial Lung Disease
- TGF-ß
- Fibrosis
- Diagnosis
- Pathogenesis
- Epidemiology
- Public Health
- Vaccine
- Treatment
- Inflammation
- Epithelial-Mesenchymal Transition
- Idiopathic Pulmonary Fibrosis
- Endothelial Dysfunction
- Genetics
- Zoonotic Infections
- Genetic Characterization
- Host-Pathogen Interactions
- Pharmacokinetics
- Vaccine Development
- Viral Pathogenesis
- Insecticide Resistance
- Drug Resistance
- Monoclonal Antibodies
- Cancer Immunotherapy
- Helminth Infections
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology16▲ 5.3×43 topics
- Pathogenesis7▲ 18×14 topics
- Public Health6▲ 4.9×9 topics
- Diagnosis5▲ 6.5×16 topics
- Vaccine4▲ 13×7 topics
- Fibrosis4▲ 28×5 topics
- Treatment4▲ 4.2×15 topics
- TGF-ß4▲ 30×4 topics
- Inflammation3▲ 1.96×24 topics
- Interstitial Lung Disease3▲ 63×2 topics
- Epithelial-Mesenchymal Transition3▲ 38×2 topics
- Immune Response3▲ 6.3×8 topics
- Idiopathic Pulmonary Fibrosis3▲ 73×1 topic
- Myofibroblast3▲ 73×1 topic
- Endothelial Dysfunction2▲ 14×4 topics
- Heart Failure2▲ 7.4×8 topics
- Genetics2▲ 4.5×9 topics
- Autoantibodies2▲ 12×6 topics
- Zoonotic Infections2▲ 50×2 topics
- Biomarkers2▲ 4.0×9 topics
- Genetic Characterization2▲ 59×2 topics
- Immunotherapy2▲ 3.9×11 topics
- Host-Pathogen Interactions2▲ 32×3 topics
- Infection2▲ 10×5 topics
- Pharmacokinetics2▲ 9.8×3 topics
- Immunosuppressive Therapy2▲ 13×6 topics
- Vaccine Development2▲ 9.9×7 topics
- Ivermectin2▲ 89×2 topics
- Viral Pathogenesis2▲ 37×2 topics
- Genomic Sequencing2▲ 19×2 topics
- Insecticide Resistance2▲ 27×3 topics
- Pathogen Transmission2▲ 31×2 topics
- Drug Resistance2▲ 6.9×5 topics
- Metagenomics2▲ 21×2 topics
- Monoclonal Antibodies2▲ 21×3 topics
- Treatment Guidelines2▲ 9.2×3 topics
- Cancer Immunotherapy1▲ 12×3 topics
- Coronavirus1▲ 8.9×2 topics
- Helminth Infections1▲ 49×2 topics
- Norovirus1▲ 40×1 topic
Which research topics does Boehringer Ingelheim (France) publish most on?
By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Viral gastroenteritis research and epidemiology, Vector-borne infectious diseases and Animal Virus Infections Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 3 works
- 2 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works
- 3 Vector-borne infectious diseases Parasitology 1 works
- 4 Animal Virus Infections Studies Animal Science and Zoology 1 works
- 5 Viral Infections and Vectors Infectious Diseases 1 works
- 6 Pharmacogenetics and Drug Metabolism Pharmacology 1 works
- 7 Animal Disease Management and Epidemiology Agronomy and Crop Science 1 works
- 8 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
- 9 Dermatological diseases and infestations Infectious Diseases 1 works
- 10 Helminth infection and control Small Animals 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (France)'s research output changed?
Output in 2018–2022 was 20% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.